Skip to main content
Erschienen in: BMC Geriatrics 1/2023

Open Access 01.12.2023 | Research

Association of cardiovascular health at old age with all-cause mortality: a prospective cohort study in China

verfasst von: Shimin Chen, Haowei Li, Shengshu Wang, Shanshan Yang, Shaohua Liu, Yang Song, Xuehang Li, Rongrong Li, Jianhua Wang, Miao Liu, Yao He

Erschienen in: BMC Geriatrics | Ausgabe 1/2023

Abstract

Background

Cardiovascular disease has become the leading cause of death worldwide, but there is a lack of data on whether cardiovascular health (CVH) is associated with elderly mortality in China. We investigated the relationship between the ideal CVH score of Chinese elderly and the all-cause mortality.

Methods

The Beijing Elderly Comprehensive Health Cohort Study included a total of 4,499 participants aged 60 years and above. The CVH metric was calculated at baseline and had a score ranging from 0 to 12. The relationship of CVH metrics with all-cause mortality was investigated using Cox proportional hazard regression analysis. The robustness of results was tested using subgroup and sensitivity analysis.

Results

The median CVH score among participants was 8.00 (2.00), with only 8.0% scoring 11–12 points. 667 deaths were observed during an average follow-up time of 8.2 years. Participants with a CVH score of 11–12 had a decreased risk of all-cause mortality when compared to those with a CVH score of 0–4(HR = 0.584, 95% CI: 0.373–0.913). Participants had a 7.5% lower risk of all-cause death with each unit higher CVH score (HR = 0.925, 95%CI: 0.885–0.967) with a linearly decreasing trend (P nonlinear = 0.575). The relationships were greater in younger elderly people and stroke patients (P interaction = 0.011 and 0.037. respectively). The consistency of significant trends in sensitivity analysis shows the robustness of association (P trend < 0.001).

Conclusions

Among the Chinese elderly, there was a linear relationship between improving CVH scores and a lower risk of all-cause mortality. Because of the enormous benefits brought by one point, strategies are essential for improving cardiovascular health attainment.

Trial registration

This study was registered at China Clinical Trial Registration Center (ChiCTR2100049866).
Hinweise

Supplementary Information

The online version contains supplementary material available at https://​doi.​org/​10.​1186/​s12877-023-04093-9.
Shimin Chen and Haowei Li these authors have contributed equally to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
CVD
Cardiovascular disease
CHD
Coronary heart disease
CVH
Cardiovascular health
BECHCS
Beijing elderly comprehensive health cohort study
HR
Hazard ratio
CI
Confidential interval
AHA
American heart association
BMI
Body mass index

Background

Cardiovascular disease (CVD) continues to be the leading cause of death and rising healthcare costs worldwide [1]. It increased the number of deaths from 12.1 million in 1990 to 18.6 million in 2019 [2], and this number is still increasing steadily [3]. Every year, nearly 4 million people in China died from CVD [4]. The number of prevalent cases reached 94 million in 2016, more than doubling that of 1990 [5]. With rapid aging, the number of people aged 65 and above will reach 366 million (26.1%) by 2050 [6], with a significant shift toward CVD in old age [7]. CVD events are expected to increase by 50% per year from 2010 to 2030 due to aging, and by 23% based on the current risk factor trend [8, 9]. The excess burden of CVD among the elderly in China poses a significant challenge to the medical and health care systems [10]. Despite advances in the medical system and health institutions in the treatment and care of CVD, the significant burden of cardiovascular disease risk factors in China continues to rise [11].
The American Heart Association (AHA) released 2020 Impact Goals in 2010 to emphasize the importance of public cardiovascular health prevention. It also defined the concept of Ideal Cardiovascular Health (ICH), also known as the Life's Simple 7 principles [12]. Since then, CVH has been widely adopted in numerous studies, aiming at promoting the interventions of modifiable health behaviors and CVD risk factors [1318]. Increasingly, studies show that having a higher level of CVH can reduce the risk of various chronic diseases (CVD events [1921], caners [22, 23], cognitive impairment [2426], and so on) and mortality [2729].
We conducted a thorough literature review prior to beginning this research. From inception to 2022/07/07, PubMed, Web of Science, and Embase were used to conduct searches. The following keywords were applied: (“ideal cardiovascular health” OR “cardiovascular health metrics” OR “life’s simple 7”) AND (“mortality” OR “death”). The reference lists of eligible literature were thoroughly searched. The effect of CVH on mortality risk has been studied in younger Chinese people [3033]: the HRs ranged from 0.54 to 0.78 (highest CVH group vs. lowest CVH group), but data for the elderly in China is limited. In view of this situation, In light of this, we intend to examine the relationship between CVH score and all-cause mortality in the elderly in China from 2009 to 2021 using data from the Beijing Elderly Comprehensive Health Cohort Study (BECHCS).

Methods

Study design and population

BECHCS was a community-based cohort study conducted in Beijing. As shown in Supplemental Fig. 1, the survey areas include Wanshou Road Community and Miyun District, which were chosen as representatives of the geographical and economic features of Beijing, China. A two-stage random cluster sampling method was used to recruit qualified subjects (aged 60 years and above, who had lived in the local areas for at least 12 months).
The baseline survey was carried out from September, 2009 to September, 2014, which included standardized questionnaires, physical examinations and laboratory tests. And follow-up data have been reviewed until 31st March, 2021 in order to collect information on mortality. We eventually included 4,499 participants after excluding those who did not follow up, had incomplete information, or had missing values.
All the experiment protocol involving human beings are in line with the guiding principles of national, international, institutional, and Declaration of Helsinki in the manuscript. The BECHCS program was approved by the Independent Ethics Committees of Chinese People’s Liberation Army General Hospital(S2021-327–01). This study was registered at China Clinical Trial Registration Center (ChiCTR2100049866). All data were anonymous to protect participants’ privacy in the research. Prior to the study, participants were given oral and written information about the study and signed informed consent forms.

Metrics and score for CVH

According to the guidelines of AHA [12] and modified according to the characteristics of the elderly in China [34], 6 metrics (include: cigarette smoking, body mass index, physical activity, total cholesterol, blood pressure and fasting plasma glucose) were used to define and monitor the status of cardiovascular health (CVH). Interview questionnaires, physical examinations, and laboratory measurements were used to collect data for each metric. The cutoff points for poor, intermediate, and ideal status in each CVH metric are listed in Supplemental Table 1. Each behavior or factor was graded as poor (0 point), intermediate (1 point), or ideal (2 points) (2 points). The CVH score was calculated by adding the sum of six CVH metrics, which ranged from 0 to 12 points.
Table 1
Characteristics of study sample at baseline based on category of residence
Characteristic
Total
Urban
Rural
P value
Age, y
70.00(10.00)
72.00(9.00)
68.00(10.00)
< 0.001
Gender
   
0.974
 Male
1814(40.3)
847(40.3)
967(40.3)
 
 Female
2685(59.7)
1255(59.7)
1430(59.7)
 
Ethnic group
   
0.002
 Han
4414(98.1)
2048(97.4)
2366(98.7)
 
 Others
85(1.9)
54(2.6)
31(1.3)
 
Marital status
   
< 0.001
 Married
1774(39.4)
1774(84.4)
0
 
 Single or widowed
2725(60.6)
328(15.6)
2397(100.0)
 
Education, y
   
< 0.001
 < 6
1199(26.7)
243(11.6)
956(39.9)
 
 6–11
2186(48.6)
774(36.8)
1412(58.9)
 
 > 11
1114(24.8)
1085(51.6)
29(1.2)
 
Alcohol drinking
   
< 0.001
 Never
2791(62.0)
1579(75.1)
1212(50.6)
 
 Former
250(5.6)
98(4.7)
152(6.3)
 
 Current
1458(32.4)
425(20.2)
1033(43.1)
 
 Coronary heart disease
934(20.8)
498(23.7)
436(18.2)
< 0.001
 Hypertension
2427(53.9)
1513(72.0)
914(38.1)
< 0.001
 Diabetes mellitus
601(13.4)
400(19.0)
201(8.4)
< 0.001
 Stroke
602(13.4)
267(12.7)
335(14.0)
0.211
 Dyslipidemia
793(17.6)
699(33.3)
94(3.9)
< 0.001
CVH metric
 Smoking status
   
< 0.001
  Never
3127(69.5)
1531(72.8)
1596(66.6)
 
  Former
594(13.2)
340(16.2)
254(10.6)
 
  Current
778(17.3)
231(11.0)
547(22.8)
 
 Physical activity, h/wk
   
< 0.001
  < 5
1780(39.6)
424(20.2)
1356(56.6)
 
  5–9
1726(38.4)
985(46.9)
741(30.9)
 
  > 9
993(22.1)
693(33.0)
300(12.5)
 
Body mass index, kg/m2
24.44(4.40)
24.84(4.22)
24.33(4.41)
< 0.001
Systolic blood pressure, mmHg
134.00(24.00)
138.00(25.00)
134.00(24.00)
< 0.001
Diastolic blood pressure, mmHg
79.00(15.00)
77.00(14.00)
80.00(14.00)
< 0.001
Total cholesterol, mmol/L
4.89(1.34)
5.22(1.32)
4.62(1.25)
< 0.001
Fasting plasma glucose, mmol/L
5.55(1.15)
5.61(1.15)
5.49(1.13)
< 0.001
Median (IQR) and number (%) were summarized for continuous variables and categorical variables, respectively. Statistical significance for continuous variables was tested for Mann–Whitney U and χ2 method was conducted for categorical variables
CVH indicates cardiovascular health

Covariates

Data on demographic characteristics, medical histories, and lifestyle were gathered using standardized questionnaires administered in person by trained interviewers. Age, gender, residence, ethnic group, marital status, education, alcohol consumption, illness history, and so on. Physical examinations of participants were performed by experienced physicians and nurses in accordance with a standardized protocol, including weight, height, and blood pressure, among other things. Overnight blood sampling testing was used in the laboratory. Blood samples were sent in less than 30 min to the Chinese PLA general hospital’s central certified laboratory.
The primary outcome was all-cause mortality. The death was recorded by the Death Registration Center of Chinese Center for Disease Control and Prevention and confirmed by the public security department. The date, causes, and location of death were recorded with unique personal identification numbers based on death certificates.

Statistical analysis

To describe the characteristics of the participants, mean (standard deviation) or median (interquartile range) values were summarized for normally distributed or non-normally distributed continuous variables, and as number (percentage) for categorical variables. Statistical significance for continuous variables was tested for Mann–Whitney U tests and χ2 method was conducted for categorical variables. We began by describing the distribution of each CVH metric by age, gender, and residential group. The percentage of each ideal CVH in each age and gender group was then depicted using a mosaic plot. The distribution of CVH scores by age, gender, and residence was depicted using percentage bar plots.
The second step was to use a restricted cubic spline with four knots to see if the relationship between CVH score and all-cause mortality fit the linear model. To confirm whether the CVH score meets the proportion hazard assumption, a survival curve with cumulative hazard was generated.
The third step was to use a Cox proportion regression model to estimate the hazard ratio (HR) and 95% confidence interval (95% CI) for the relationship between CVH score and all-cause mortality (crude, and controlling for age, gender, residence, ethnic group, marital status, education, alcohol drinking, previous coronary heart disease and stroke). Then the population attributable fraction (PAF) among CVH score groups was then calculated using the formula: \(\mathrm{PAF}=\frac{\mathrm{pe}(\mathrm{HR}-1)}{1+\mathrm{pe}(\mathrm{HR}-1)}\), pe refers to the proportion of exposed subjects in the population. The Mann–Kendall trend for mortality rate or density was used to calculate P, and CVH score was used as a continuous variable in the regression model.
Finally, to test the robustness and potential variations in different subgroups, we repeated all of the Cox proportional regressions stratified by age, gender, residence, ethnic group, marital status, education, alcohol consumption, previous CHD, and previous stroke groups, with CVH score as a continuous variable. Sensitivity analysis was performed: (1) excluding participants who had CHD or stroke previously; (2) excluding participants whose BMI is lower than 18 kg/m2; (3) excluding participants who have been followed up for less than 2 years; and (4) using propensity score weighted method with inverse probability of treatment weighting was adopted so as to test the robustness of results.
The statistical analyses were performed using SPSS 26.0 (SPSS Inc., IBM, Armonk, NY, USA) and R 4.1.2 (The R Foundation for Statistical Computing, Vienna, Austria; www.​R-project.​org). Two-sided P-values of < 0.05 were considered statistically significant.

Results

Baseline characteristics

The study sample consisted of 4,499 subjects, the baseline characteristics of whom are compared by the residence in Table 1. At the baseline survey, the average age of study population at baseline survey was 70.49(SD 6.77) years old, with 40.3% males and 98.1% Han nationality. Participants in urban areas had higher levels of education and morbidity than those in rural areas (CHD, hypertension, diabetes and dyslipidemia). Each crude CVH metric difference between residences was statistically significant (P < 0.001).

CVH metrics and scores

Table 2 shows the distribution of CVH metrics by gender, age, and residence group. Males had more ideal metrics than females (BMI, BP, TC, FPG), and urban residents had a higher rate of ideal CVH only in current smoking and physical activity. Figure 1 depicts additional subgroup combinations of ideal CVH metrics. In the smoking metric, female participants under the age of 75 had the highest ideal CVH percentage, while male participants living in rural areas performed well in the BMI metric. In comparison to the averaged expected value of ideal fasting plasma glucose, the proportion of male participants under 75 years old who lived in rural areas was relatively high, while the proportion of female participants under 75 years old who lived in urban areas was lower. Figure 2 depicts the distribution of CVH scores by subgroup. Only 8% of study participants had 11–12 points (only 1.6% had all six ideal CVH metrics), and the same centralized pattern was observed in each subgroup. The median CVH score in the study population was 8.00 (2.00). The CVH score was generally higher in participants who were under 75 years old and lower in participants who were over 75 years old.
Table 2
Distribution of cardiovascular health metrics and score in BECHCSa
Item
Overall
Gender
Age
Residence
N (%)
Male
Female
< 75
≥ 75
Urban
Rural
Current smoking
  
< 0.001
 
0.233
 
< 0.001
 Yes
778(17.3)
671(37.0)
107(4.0)
572(17.9)
206(15.9)
231(11.0)
574(22.8)
 Former, quit ≤ 12 months
58(1.3)
52(2.9)
6(0.2)
39(1.2)
19(1.5)
14(0.7)
44(1.8)
 Never or quit > 12 months
3663(81.4)
1091(60.1)
2572(95.8)
2590(80.9)
1073(82.7)
1857(88.3)
1806(75.3)
Body mass index
  
< 0.001
 
0.068
 
< 0.001
 ≥ 30.0 kg/m2
270(6.0)
65(3.6)
205(7.6)
194(6.1)
76(5.9)
137(6.5)
133(5.5)
 25.0–29.9 kg/m2
1637(36.4)
615(33.9)
1022(38.1)
1197(37.4)
440(33.9)
873(41.5)
764(31.9)
 < 25.0 kg/m2
2592(57.6)
1134(62.5)
1458(54.3)
1810(56.5)
782(60.2)
1092(52.0)
1500(62.6)
Physical activity
  
0.005
 
0.351
 
< 0.001
 Poor
1156(25.7)
511(28.2)
645(24.0)
834(26.1)
322(24.8)
112(5.3)
1044(43.6)
 Intermediate
624(13.9)
233(12.8)
391(14.6)
430(13.4)
194(14.9)
312(14.8)
312(13.0)
 Ideal
2719(60.4)
1070(59.0)
1649(61.4)
1937(60.5)
782(60.2)
1678(79.8)
1041(43.4)
Blood pressure
  
< 0.001
 
< 0.001
 
< 0.001
 ≥ 140 or ≥ 90 mmHg
1928(42.9)
711(39.2)
1217(45.3)
1297(40.5)
631(48.6)
1006(47.9)
922(38.5)
 120–139 or 80-89 mmHg
1848(41.1)
776(42.8)
1072(39.9)
1348(42.1)
500(38.5)
815(38.8)
1033(43.1)
 < 120 or < 90 mmHg
723(16.1)
327(18.0)
396(14.7)
556(17.4)
167(12.9)
281(13.4)
442(18.4)
Total cholesterol
  
< 0.001
 
0.781
 
< 0.001
 ≥ 240 mg/dL
544(12.1)
124(6.8)
420(15.6)
389(12.2)
155(11.9)
377(17.9)
167(7.0)
 200-239 mg/dL
1239(27.5)
374(20.6)
865(32.2)
872(27.2)
367(28.3)
724(34.4)
515(21.5)
 < 200 mg/dL
2716(60.4)
1316(72.5)
1400(52.1)
1940(60.6)
776(59.8)
1001(47.6)
1715(71.5)
Fasting plasma glucose
  
0.001
 
0.469
 
< 0.001
 ≥ 126 mg/dL
652(14.5)
226(12.5)
426(15.9)
477(14.9)
175(13.5)
332(15.8)
320(13.4)
 100-125 mg/dL
1581(35.1)
627(34.6)
954(35.5)
1118(34.9)
463(35.7)
784(37.3)
797(33.2)
 < 100 mg/dL
2266(50.4)
961(53.0)
1305(48.6)
1606(50.2)
660(50.8)
986(46.9)
1280(53.4)
CVH score, median (IQR)
8.00(2.00)
8.00(2.00)
8.00(2.00)
8.00(2.00)
8.00(2.00)
8.00(2.00)
8.00(2.00)
 Behavior
5.00(2.00)
4.00(2.00)
5.00(2.00)
5.00(2.00)
5.00(2.00)
4.00(2.00)
5.00(2.00)
 Factor
4.00(1.00)
4.00(2.00)
3.00(1.00)
4.00(2.00)
4.00(1.00)
4.00(2.00)
3.00(2.00)
aBECHCS Beijing elderly comprehensive health cohort study. χ2 method was conducted for categorical variables

Association of CVH score with all-cause mortality

As Fig. 3 shows, the risk of all-cause mortality decreased linearly (P nonlinear = 0.654) as the CVH score increased in restricted cubic spline (RCS) curve. In Supplemental Fig. 2, P values for nonlinear were 0.571, 0.570, and 0.575, respectively, for RCS curves with gradual adjustment. With a CVH score of 0–4 as a reference, each CVH score group was separated and the Cox regression assumption was followed.
There were 667 deaths among the study population during the average follow-up period of 8.13 years (36595.72 person-years). Subjects with a CVH score of 0–4 points had the highest rate and density of mortality [rate:24.26 (21.87,26.83); density: 33.02 (29.42,37.05) per 1,000 person years], while subjects with a CVH score of 11–12 points had a sharp decrease [rate: 13.33(12.17,14.59); density: 16.38 (14.87,18.03) per 1,000 person years]. In addition, as the CVH score increased, so did the survival rate.
Table 3 shows the association estimated by Cox regression. In all models with gradual adjustments, participants with a CVH score of 6 to 10 and 11–12 had a lower risk of all-cause mortality compared to those with a score of 0–4. After gradually adjusting the potential confounders in four models, participants with highest CVH score were associated with 52.0%, 51.0%, 44.6%, 41.6% reduced risk of all-cause mortality [model 1: HR = 0.480, 95%CI: (0.308,0.747); model 2: HR = 0.490, 95%CI: (0.314,0.763); model 3: HR = 0.554, 95%CI: (0.355,0.865); model 4: HR = 0.584, 95%CI: (0.373,0.913)] than that with lowest CVH score group.1.42%, 4.49%, 7.03%, 7.13%, 12.31%, 8.31% and 3.44% of the deaths could be avoided if the study population shifted to a CVH score ranged from 5 to 10 and 11–12, respectively. The HRs (95% CIs) of per point higher CVH score with gradual adjustment for all-cause mortality for continuous CVH score were 0.900 (0.863,0.939), 0.907 (0.870,0.947), 0.925 (0.886,0.965), and 0.928 (0.889,0.969), respectively.
Table 3
Cox proportional hazard model for the association of CVH with all-cause mortality
All-cause mortality
Mortality rate
Mortality density
Model 1a
Model 2b
Model 3c
Model 4d
PAFd, %
Death/N
Percentage, %
n/person-year
per 1,000 person-years
HR (95%CI)
Continuous
667/4499
14.83(14.47,15.19)
667/36595.72
18.23(17.76,18.70)
0.900(0.863,0.939)
0.907(0.870,0.947)
0.925(0.886,0.965)
0.928(0.889,0.969)
 
 0–4
33/136
24.26(21.87,26.83)
33/999.32
33.02(29.42,37.05)
Reference
Reference
Reference
Reference
-
 5
42/227
18.50(16.83,20.30)
42/1710.66
24.55(22.15,27.20)
0.741(0.469,1.168)
0.668(0.423,1.054)
0.686(0.434,1.083)
0.723(0.457,1.143)
-1.42
 6
72/479
15.03(13.96,16.17)
72/3714.11
19.39(17.92,20.97)
0.582(0.386,0.879)
0.559(0.370,0.844)
0.571(0.378,0.863)
0.596(0.394,0.902)
-4.49
 7
121/794
15.24(14.40,16.12)
121/6314.21
19.16(18.03,20.36)
0.568(0.386,0.834)
0.559(0.381,0.822)
0.603(0.410,0.888)
0.628(0.427,0.925)
-7.03
 8
166/944
17.58(16.76,18.44)
166/7678.70
21.62(20.53,22.77)
0.643(0.436,0.921)
0.610(0.420,0.887)
0.650(0.447,0.946)
0.683(0.468,0.995)
-7.13
 9
107/900
11.88(11.18,12.64)
107/7644.53
14.00(13.12,14.93)
0.402(0.272,0.594)
0.395(0.267,0.584)
0.435(0.294,0.645)
0.452(0.304,0.670)
-12.31
 10
78/659
11.84(11.01,12.71)
78/5603.05
13.92(12.90,15.02)
0.402(0.267,0.604)
0.395(0.262,0.594)
0.448(0.297,0.675)
0.476(0.315,0.720)
-8.31
 11–12
48/360
13.33(12.17,14.59)
48/2931.13
16.38(14.87,18.03)
0.480(0.308,0.747)
0.490(0.314,0.763)
0.554(0.355,0.865)
0.584(0.373,0.913)
-3.44
P for trend
z = -2.103
P = 0.035
z = -2.351
P = 0.0187
< 0.001
< 0.001
< 0.001
0.001
 
aModel 1: unadjusted crude model. Model 2: adjusted for age, gender, residence. Model 3: adjusted based on model 2 plus ethnic group, marital status, education, alcohol drinking. Model 4: adjusted based on model 3 plus previous coronary heart disease and previous stroke
b95% confidential intervals for mortality rate and density were based on Binomial Probabilities
cThe value of P for trend was calculated by Mann–Kendall trend test for mortality rate and density. For the regression, P for trend was computed by including CVH score as continuous variable
dPAF: attributable fraction, \(\mathrm{PAF}=\frac{\mathrm{pe}(\mathrm{HR}-1)}{1+\mathrm{pe}(\mathrm{HR}-1)}\), pe refers to the proportion of exposed subjects in the population

Subgroup and sensitivity analyses

Figure 4 depicts forest plots for subgroup analysis to estimate the association of CVH score with all-cause mortality with full adjustments. Each one-unit higher CVH score was associated with lower all-cause mortality in younger adults(< 75 years old) compared to older adults (≥ 75 years old), and in participants with previous stroke compared to those without previous stroke (P for interaction = 0.011 and 0.037, respectively). Other subgroups' results were not significantly different. Given the power of model, we further adjusted the numbers of potential confounders (Supplemental Fig. 3). Sensitivity analyses were performed in Table 4 to test the robustness of the association. After excluding participants who had previously had CHD or stroke (1356), those with BMI less than 18 kg/m2 (100), and those who died within 2 years of follow-up (95), and using the propensity score weighting method for all participants individually, the results remained consistent.
Table 4
Sensitivity analysis for the association of CVH score with all-cause mortality
 
Model 1b
Model 2b
Model 3b
Participants without prior CHDa or stroke, n/total = 406/3143
0–4, n/total = 15/79
Reference
Reference
Reference
5, n/total = 24/155
0.639(0.355,1.151)
0.566(0.314,1.02)
0.566(0.314,1.020)
6, n/total = 43/336
0.633(0.363,1.105)
0.606(0.347,1.059)
0.653(0.373,1.143)
7, n/total = 72/548
0.709(0.412,1.219)
0.634(0.368,1.092)
0.682(0.395,1.177)
8, n/total = 103/669
0.496(0.284,0.866)
0.478(0.273,0.837)
0.525(0.299,0.920)
9, n/total = 70/616
0.453(0.255,0.808)
0.417(0.233,0.745)
0.477(0.266,0.853)
10, n/total = 50/477
0.498(0.267,0.929)
0.495(0.265,0.925)
0.566(0.302,1.059)
11–12, n/total = 29/263
0.790(0.415,1.506)
0.639(0.335,1.219)
0.649(0.340,1.238)
P for trendc
0.001
0.004
0.044
Participants with BMI over 18 kg/m2, n/total = 645/4399
0–4, n/total = 33/136
Reference
Reference
Reference
5, n/total = 42/225
0.585(0.388,0.884)
0.567(0.376,0.857)
0.607(0.401,0.918)
6, n/total = 72/475
0.569(0.387,0.836)
0.565(0.384,0.831)
0.636(0.432,0.937)
7, n/total = 120/784
0.618(0.425,0.900)
0.600(0.412,0.874)
0.675(0.462,0.985)
8, n/total = 159/915
0.389(0.263,0.576)
0.382(0.258,0.567)
0.437(0.294,0.650)
9, n/total = 103/886
0.399(0.265,0.601)
0.393(0.261,0.593)
0.476(0.314,0.721)
10, n/total = 75/636
0.426(0.269,0.673)
0.447(0.283,0.707)
0.539(0.340,0.856)
11–12, n/total = 41/342
0.744(0.472,1.175)
0.672(0.425,1.060)
0.729(0.461,1.153)
P for trendc
< 0.001
 < 0.001
< 0.001
Participants with follow-up time over 2 years, n/total = 573/4404
0–4, n/total = 28/131
Reference
Reference
Reference
5, n/total = 31/216
0.641(0.384,1.068)
0.573(0.344,0.956)
0.619(0.370,1.035)
6, n/total = 62/469
0.585(0.374,0.914)
0.554(0.354,0.865)
0.592(0.378,0.927)
7, n/total = 110/783
0.599(0.396,0.907)
0.579(0.382,0.878)
0.657(0.433,0.998)
8, n/total = 145/923
0.639(0.426,0.958)
0.603(0.402,0.905)
0.681(0.453,1.024)
9, n/total = 87/880
0.373(0.244,0.572)
0.356(0.232,0.546)
0.412(0.268,0.633)
10, n/total = 69/650
0.406(0.262,0.630)
0.389(0.251,0.605)
0.479(0.306,0.748)
11–12, n/total = 41/352
0.472(0.292,0.763)
0.478(0.296,0.773)
0.581(0.358,0.944)
P for trendc
< 0.001
< 0.001
< 0.001
All participants analyzed with PSWd, n/total = 667/4499
0–4, n/total = 33/136
Reference
Reference
Reference
5, n/total = 42/227
0.740(0.466,1.176)
0.742(0.467,1.179)
0.739(0.465,1.175)
6, n/total = 72/479
0.579(0.381,0.880)
0.580(0.382,0.881)
0.580(0.382,0.881)
7, n/total = 121/794
0.568(0.384,0.842)
0.564(0.381,0.836)
0.564(0.381,0.836)
8, n/total = 166/944
0.634(0.433,0.928)
0.638(0.436,0.934)
0.640(0.437,0.938)
9, n/total = 107/900
0.403(0.271,0.601)
0.406(0.273,0.606)
0.408(0.274,0.609)
10, n/total = 78/659
0.401(0.265,0.606)
0.410(0.271,0.620)
0.412(0.272,0.624)
11–12, n/total = 48/360
0.481(0.306,0.756)
0.478(0.304,0.751)
0.483(0.307,0.760)
P for trendc
< 0.001
< 0.001
< 0.001
aCHD: coronary heart disease
bModel 1: unadjusted crude model. Model 2: adjusted for age, gender, residence. Model 3: adjusted based on model 2 plus ethnic group, marital status, education, alcohol drinking, previous coronary heart disease and stroke
cP for trend was computed by including CVH score as continuous variable
dPSW: propensity score weighted method; inverse probability of treatment weighting was applied for gradual adjustment of covariates. Model 1: age, gender and residence; Model 2: based on model 2 plus ethnic group, marital status, education and alcohol drinking; Model 3: based on model 3 plus previous coronary heart disease and stroke

Discussion

This study investigated the relationship between CVH score with all-cause mortality among Chinese elderly: the higher the CVH score in old age, the lower the risk of all-cause mortality; and a linear-dose response relationship was observed. In both male and female population, consistent relationships were found between the obtainment of per point in CVH score and the reduced risk of mortality. This study provides evidence that CVH metrics can reduce the risk of all-cause mortality in the Chinese elderly population.
The prevalence of ideal CVH in Chinese elderly remains low. Our study found that 8% of the participants scored 11–12 points in CVH, and only 1.6% got all six metrics of ideal CVH. This result was consistent with a previous study [35], it included 5026 participants aged 65 and above in rural China, and found that only 0.8% of them met the ideal levels for 6 CVH metrics. Several studies have found a low prevalence of ideal CVH: 5% [36] (participants had ≥ 5 out of 7 metrics at the ideal level), 12% [37] (participants had 9–12 out of 12 points of CVH score), 6.5% [25] (participants had 5 to 7 health metrics at optimal levels). Due to the various definitions of ideal CVH, the distribution of CVH metrics components varies from one another. In our study, the low prevalence of ideal CVH resulted in the unfavorable blood pressure level: only 16.1% of all the subjects achieved the ideal state. It could be partially due to the use of biomass fuel [38] or a diet with high sodium [39]. In China, the hypertension is common, accounting for 33.0–47.2 of atherosclerotic CVD events [40], while the control rate is low [41]. Immediate actions are required in China to improve the prevention or treatment of hypertension in the elderly. Furthermore, because the score of metabolic CVH metrics would be affected by behavior metrics, composite metrics would be expected to be lower [20].
In this study, the CVH score was generally higher among the elderly men under 75 years old who live in the rural areas. Bi et al. investigated a nationally representative sample of 96,121 Chinese adults aged 20 years and older in 2010 and discovered that being female and being younger were the protective factors for cardiovascular health [42]. While Han et al. reported men were more likely than women to achieve ideal levels on all CVH metrics, smoking was not one of them [35]. Of note, smoking metric directed primarily at the sex difference in global and behavior CVH metrics, where males outnumber females in terms of smoking prevalence.. The same patterns were observed in urban and rural disparities. The inconsistency is likely due to the fact that premenopausal women are relatively unaffected by CVD risk, whereas sex disparity diminishes with age after menopause [43]. Previous studies found that the oldest old and centenarians had a higher overall level of CVH metrics than the young elderly [11, 34, 44, 45], but the prevalence of ideal CVH still needs to be improved. Furthermore, the difference between gender, age and residence in our study could be influenced by the population characteristics in our study as well as the sample size of subgroups. More related studies are favorable.
Strong associations of the CVH metrics with all-cause mortality have been confirmed. Our study found that the risk among Chinese elderly with CVH score at 11–12 points was 41.6% lower than that of those with a CVH score of 0–4 points (HR = 0.584, 95% CI: 0.373–0.913). As the number of CVH metrics increased, the risk of all-cause mortality decreased continuously and linearly[HR = 0.925, 85%CI: (0.885,0.967); (P nonlinear = 0.575)]. In lined with our findings, Zhou et al. found that in the Chinese population, participants with higher ideal CVH metrics had a 54% lower risk of all-cause mortality compared to those with lower ideal metrics [32]. A stronger protective effect was observed in comparison to previous studies in younger adults [3033]. The linear dose–response relationship was consistent with a meta-analysis [27], which included 142,137 participants to quantify the mortality risk of each unit change in ideal CVH and found that there is a linear inverse relationship. Previous studies [31, 4648] recognized this close relationship, which were summarized in a meta-analysis [28], and the evidence was well established among younger populations. For older age adults, Gaye et al. conducted a Three-City Study to examine the benefit of higher CVH status in terms of mortality among participants aged 65 years and over [36]. The estimated HR (95% CI) was 0.71 (0.55–0.90) of all-cause mortality among subjects with ≥ 5 vs. ≤ 2 ideal metrics was assessed. Several studies in the Korean and British elderly population [34, 37] confirmed the evidence of an association between CVH and cardiovascular events in the elderly population. Then, our findings supplemented this gap among Chinese elderly even more. With the increase of ideal CVH score, the risk of all-cause mortality reduction was consistent across all age groups, highlighting the importance of promoting CVH metrics in old age. Furthermore, because the linear relationship was shown to be statistically significant, it should be emphasized that improving every point of CVH score- that is, shifting each CVH metric from poor into intermediate- systematically yielded favorable outcomes [18]. While achieving the ideal CVH is undoubtedly a long-term goal, the immediate action or short-term goal is to encourage the attainment of per point of CVH score at a time progressively [36].
Subgroup analysis could provide supporting evidence for more efficient methods of promoting CVH metrics in the elderly. In the age-stratified analysis, the decreasing trend in the risk of all-cause mortality with increasing CVH score was statistically significant among the younger elderly (age under 75 years), but not among the very elderly (age 75 years and above). The reason accounting for this could be “survivor bias”, which means that participants had to live to reach age 75 years old or older before the assessment of CVH score [49]. This shows the importance of paying special attention to the young and elderly when providing prevention or care. In the stroke-stratified analysis, more considerations are favorable to determine the difference of pattern of CVH metrics among older adults with stroke. In our study, individuals in rural areas tended to have higher levels of unhealthy lifestyles. According to current research [11, 18, 21], the disparity in health behavior between urban and rural areas is partly explained by socioeconomic development factors such as income and education level. This suggests that public health policies and strategies should be implemented especially focusing on behavior interventions for Chinese elderly in rural areas.
There are several limitations to the study. First, the prevalence of ideal CVH metrics in this study should be generalized with caution, given the non-nationally representative study population. The primary goal of our study was to evaluate the association of CVH score with all-cause mortality in the elderly. Further research into the epidemiology of CVH among the elderly in China would benefit from larger-scale or nationwide samples of the elderly. Second, data about lifestyles and diseases were self-reported, which could lead to recall bias. To address this problem, highly stringent training procedures and quality assurance programs were implemented throughout the research process. Including recruiting trained interviewees, requiring certificate of disease diagnosis, etc. if possible. Third, individuals with prior CVD were included in the analysis throughout, which might bring over estimation of the reported associations. To address this problem, sensitivity analysis was performed to exclude subjects with CHD or stroke, ensuring robustness of results. Besides, subjects with extremely low BMI or who died two years after follow-up were also excluded to account for misclassification bias. Fourth, detailed information was absent. To avoid classification bias and remain consist with previous study, we revised Life’s Simple 7 into 6 metrics. And because all of the data was measured once, any differences between the baseline survey and the endpoint investigation may have gone unnoticed. Furthermore, the risk of CVD mortality wasn’t estimated. Fifth, the sample sizes limited further stratified analysis or potential confounders. Considering the power of statistical analysis, we did gradual adjustments with 4 models, which might explain the reason why some associations were not statically significant.

Conclusion

Among the Chinese elderly, there was a linear rekationship between CVH scores and the lower risk of all-cause mortality. It is critical to develop strategies to improve cardiovascular health attainment among Chinese elderly with low CVH scores.

Acknowledgements

The authors sincerely appreciate the contributions of staffs and participants at Beijing Elderly Comprehensive Health Cohort Study (BECHCS).

Declarations

All the experiment protocol for involving humans was in accordance to guidelines of national, international, institutional, and Declaration of Helsinki in the manuscript. The Independent Ethics Committees of Chinese People’s Liberation Army General Hospital approved the BECHCS protocol (S2021-327–01). The researcher provided information about the purpose of the study to the participants and the informed consent were signed.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
1.
Zurück zum Zitat Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529–32.PubMedCrossRef Mensah GA, Roth GA, Fuster V. The global burden of cardiovascular diseases and risk factors: 2020 and beyond. J Am Coll Cardiol. 2019;74(20):2529–32.PubMedCrossRef
2.
Zurück zum Zitat Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, Baddour LM, Barengo NC, Beaton AZ, Benjamin EJ, Benziger CP, et al. Global burden of cardiovascular diseases and risk factors, 1990–2019: update from the GBD 2019 Study. J Am Coll Cardiol. 2020;76(25):2982–3021.PubMedPubMedCentralCrossRef
3.
Zurück zum Zitat Figtree GA, Broadfoot K, Casadei B, Califf R, Crea F, Drummond GR, Freedman JE, Guzik TJ, Harrison D, Hausenloy DJ, et al. A call to action for new global approaches to cardiovascular disease drug solutions. Eur Heart J. 2021;42(15):1464–75.PubMedCrossRef Figtree GA, Broadfoot K, Casadei B, Califf R, Crea F, Drummond GR, Freedman JE, Guzik TJ, Harrison D, Hausenloy DJ, et al. A call to action for new global approaches to cardiovascular disease drug solutions. Eur Heart J. 2021;42(15):1464–75.PubMedCrossRef
4.
Zurück zum Zitat Li X, Wu C, Lu J, Chen B, Li Y, Yang Y, Hu S, Li J. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. 2020;5(12):e672–81.PubMedCrossRef Li X, Wu C, Lu J, Chen B, Li Y, Yang Y, Hu S, Li J. Cardiovascular risk factors in China: a nationwide population-based cohort study. Lancet Public Health. 2020;5(12):e672–81.PubMedCrossRef
5.
Zurück zum Zitat Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, Liu Y, Liu J, Qi J, Ran S, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342–52.PubMedPubMedCentralCrossRef Liu S, Li Y, Zeng X, Wang H, Yin P, Wang L, Liu Y, Liu J, Qi J, Ran S, et al. Burden of cardiovascular diseases in China, 1990–2016: findings from the 2016 global burden of disease study. JAMA Cardiol. 2019;4(4):342–52.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Feng Z, Glinskaya E, Chen H, Gong S, Qiu Y, Xu J, Yip W. Long-term care system for older adults in China: policy landscape, challenges, and future prospects. Lancet. 2020;396(10259):1362–72.PubMedCrossRef Feng Z, Glinskaya E, Chen H, Gong S, Qiu Y, Xu J, Yip W. Long-term care system for older adults in China: policy landscape, challenges, and future prospects. Lancet. 2020;396(10259):1362–72.PubMedCrossRef
7.
Zurück zum Zitat Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–12.PubMedCrossRef Zhao D, Liu J, Wang M, Zhang X, Zhou M. Epidemiology of cardiovascular disease in China: current features and implications. Nat Rev Cardiol. 2019;16(4):203–12.PubMedCrossRef
8.
Zurück zum Zitat Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010;3(3):243–52.PubMedPubMedCentralCrossRef Moran A, Gu D, Zhao D, Coxson P, Wang YC, Chen CS, Liu J, Cheng J, Bibbins-Domingo K, Shen YM, et al. Future cardiovascular disease in china: markov model and risk factor scenario projections from the coronary heart disease policy model-china. Circ Cardiovasc Qual Outcomes. 2010;3(3):243–52.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Moran A, Zhao D, Gu D, Coxson P, Chen CS, Cheng J, Liu J, He J, Goldman L. The future impact of population growth and aging on coronary heart disease in China: projections from the coronary heart disease policy model-China. BMC Public Health. 2008;8:394.PubMedPubMedCentralCrossRef Moran A, Zhao D, Gu D, Coxson P, Chen CS, Cheng J, Liu J, He J, Goldman L. The future impact of population growth and aging on coronary heart disease in China: projections from the coronary heart disease policy model-China. BMC Public Health. 2008;8:394.PubMedPubMedCentralCrossRef
10.
Zurück zum Zitat Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145–58.PubMedPubMedCentralCrossRef Zhou M, Wang H, Zeng X, Yin P, Zhu J, Chen W, Li X, Wang L, Wang L, Liu Y, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2019;394(10204):1145–58.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Zhang M, Shi Y, Shi O, Zhao Z, Zhang X, Li C, Huang Z, Zhao L, Wang L, Li Y, et al. Geographical variations in cardiovascular health in China: a nationwide population-based survey of 74,726 adults. Lancet Reg Health West Pac. 2020;3:100033.PubMedPubMedCentralCrossRef Zhang M, Shi Y, Shi O, Zhao Z, Zhang X, Li C, Huang Z, Zhao L, Wang L, Li Y, et al. Geographical variations in cardiovascular health in China: a nationwide population-based survey of 74,726 adults. Lancet Reg Health West Pac. 2020;3:100033.PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.PubMedCrossRef Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American heart association’s strategic impact goal through 2020 and beyond. Circulation. 2010;121(4):586–613.PubMedCrossRef
13.
Zurück zum Zitat Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–83.PubMedPubMedCentralCrossRef Yang Q, Cogswell ME, Flanders WD, Hong Y, Zhang Z, Loustalot F, Gillespie C, Merritt R, Hu FB. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA. 2012;307(12):1273–83.PubMedPubMedCentralCrossRef
14.
Zurück zum Zitat Shah AM, Claggett B, Folsom AR, Lutsey PL, Ballantyne CM, Heiss G, Solomon SD. Ideal cardiovascular health during adult life and cardiovascular structure and function among the elderly. Circulation. 2015;132(21):1979–89.PubMedPubMedCentralCrossRef Shah AM, Claggett B, Folsom AR, Lutsey PL, Ballantyne CM, Heiss G, Solomon SD. Ideal cardiovascular health during adult life and cardiovascular structure and function among the elderly. Circulation. 2015;132(21):1979–89.PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Shay CM, Gooding HS, Murillo R, Foraker R. Understanding and improving cardiovascular health: an update on the American heart association’s concept of cardiovascular health. Prog Cardiovasc Dis. 2015;58(1):41–9.PubMedCrossRef Shay CM, Gooding HS, Murillo R, Foraker R. Understanding and improving cardiovascular health: an update on the American heart association’s concept of cardiovascular health. Prog Cardiovasc Dis. 2015;58(1):41–9.PubMedCrossRef
16.
Zurück zum Zitat Younus A, Aneni EC, Spatz ES, Osondu CU, Roberson L, Ogunmoroti O, Malik R, Ali SS, Aziz M, Feldman T, et al. A systematic review of the prevalence and outcomes of ideal cardiovascular health in US and non-US populations. Mayo Clin Proc. 2016;91(5):649–70.PubMedCrossRef Younus A, Aneni EC, Spatz ES, Osondu CU, Roberson L, Ogunmoroti O, Malik R, Ali SS, Aziz M, Feldman T, et al. A systematic review of the prevalence and outcomes of ideal cardiovascular health in US and non-US populations. Mayo Clin Proc. 2016;91(5):649–70.PubMedCrossRef
17.
Zurück zum Zitat Sabia S, Fayosse A, Dumurgier J, Schnitzler A, Empana JP, Ebmeier KP, Dugravot A, Kivimäki M, Singh-Manoux A. Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study. BMJ. 2019;366:l4414.PubMedPubMedCentralCrossRef Sabia S, Fayosse A, Dumurgier J, Schnitzler A, Empana JP, Ebmeier KP, Dugravot A, Kivimäki M, Singh-Manoux A. Association of ideal cardiovascular health at age 50 with incidence of dementia: 25 year follow-up of Whitehall II cohort study. BMJ. 2019;366:l4414.PubMedPubMedCentralCrossRef
18.
Zurück zum Zitat Foraker RE, Benziger CP, DeBarmore BM, Cené CW, Loustalot F, Khan Y, Anderson CAM, Roger VL. Achieving optimal population cardiovascular health requires an interdisciplinary team and a learning healthcare system: a scientific statement from the American heart association. Circulation. 2021;143(2):e9–18.PubMedCrossRef Foraker RE, Benziger CP, DeBarmore BM, Cené CW, Loustalot F, Khan Y, Anderson CAM, Roger VL. Achieving optimal population cardiovascular health requires an interdisciplinary team and a learning healthcare system: a scientific statement from the American heart association. Circulation. 2021;143(2):e9–18.PubMedCrossRef
19.
Zurück zum Zitat van Sloten TT, Tafflet M, Périer MC, Dugravot A, Climie RED, Singh-Manoux A, Empana JP. Association of change in cardiovascular risk factors with incident cardiovascular events. JAMA. 2018;320(17):1793–804.PubMedPubMedCentralCrossRef van Sloten TT, Tafflet M, Périer MC, Dugravot A, Climie RED, Singh-Manoux A, Empana JP. Association of change in cardiovascular risk factors with incident cardiovascular events. JAMA. 2018;320(17):1793–804.PubMedPubMedCentralCrossRef
20.
Zurück zum Zitat Wang T, Lu J, Su Q, Chen Y, Bi Y, Mu Y, Chen L, Hu R, Tang X, Yu X, et al. ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 2019;4(9):874–83.PubMedPubMedCentralCrossRef Wang T, Lu J, Su Q, Chen Y, Bi Y, Mu Y, Chen L, Hu R, Tang X, Yu X, et al. ideal cardiovascular health metrics and major cardiovascular events in patients with prediabetes and diabetes. JAMA Cardiol. 2019;4(9):874–83.PubMedPubMedCentralCrossRef
21.
Zurück zum Zitat Perak AM, Ning H, Khan SS, Bundy JD, Allen NB, Lewis CE, Jacobs DR Jr, Van Horn LV, Lloyd-Jones DM. Associations of late adolescent or young adult cardiovascular health with premature cardiovascular disease and mortality. J Am Coll Cardiol. 2020;76(23):2695–707.PubMedPubMedCentralCrossRef Perak AM, Ning H, Khan SS, Bundy JD, Allen NB, Lewis CE, Jacobs DR Jr, Van Horn LV, Lloyd-Jones DM. Associations of late adolescent or young adult cardiovascular health with premature cardiovascular disease and mortality. J Am Coll Cardiol. 2020;76(23):2695–707.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Rasmussen-Torvik LJ, Shay CM, Abramson JG, Friedrich CA, Nettleton JA, Prizment AE, Folsom AR. Ideal cardiovascular health is inversely associated with incident cancer: the atherosclerosis risk in communities study. Circulation. 2013;127(12):1270–5.PubMedPubMedCentralCrossRef Rasmussen-Torvik LJ, Shay CM, Abramson JG, Friedrich CA, Nettleton JA, Prizment AE, Folsom AR. Ideal cardiovascular health is inversely associated with incident cancer: the atherosclerosis risk in communities study. Circulation. 2013;127(12):1270–5.PubMedPubMedCentralCrossRef
23.
Zurück zum Zitat Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, Suthahar N, Cheng S, Splansky GL, Januzzi JL Jr, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48–58.PubMedPubMedCentralCrossRef Lau ES, Paniagua SM, Liu E, Jovani M, Li SX, Takvorian K, Suthahar N, Cheng S, Splansky GL, Januzzi JL Jr, et al. Cardiovascular risk factors are associated with future cancer. JACC CardioOncol. 2021;3(1):48–58.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat González HM, Tarraf W, Harrison K, Windham BG, Tingle J, Alonso A, Griswold M, Heiss G, Knopman D, Mosley TH. Midlife cardiovascular health and 20-year cognitive decline: atherosclerosis risk in communities study results. Alzheimers Dement. 2018;14(5):579–89.PubMedCrossRef González HM, Tarraf W, Harrison K, Windham BG, Tingle J, Alonso A, Griswold M, Heiss G, Knopman D, Mosley TH. Midlife cardiovascular health and 20-year cognitive decline: atherosclerosis risk in communities study results. Alzheimers Dement. 2018;14(5):579–89.PubMedCrossRef
25.
Zurück zum Zitat Samieri C, Perier MC, Gaye B, Proust-Lima C, Helmer C, Dartigues JF, Berr C, Tzourio C, Empana JP. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA. 2018;320(7):657–64.PubMedPubMedCentralCrossRef Samieri C, Perier MC, Gaye B, Proust-Lima C, Helmer C, Dartigues JF, Berr C, Tzourio C, Empana JP. Association of cardiovascular health level in older age with cognitive decline and incident dementia. JAMA. 2018;320(7):657–64.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Speh A, Wang R, Winblad B, Kramberger MG, Bäckman L, Qiu C, Laukka EJ. The relationship between cardiovascular health and rate of cognitive decline in young-old and old-old adults: a population-based study. J Alzheimers Dis. 2021;84(4):1523–37.PubMedPubMedCentralCrossRef Speh A, Wang R, Winblad B, Kramberger MG, Bäckman L, Qiu C, Laukka EJ. The relationship between cardiovascular health and rate of cognitive decline in young-old and old-old adults: a population-based study. J Alzheimers Dis. 2021;84(4):1523–37.PubMedPubMedCentralCrossRef
27.
Zurück zum Zitat Aneni EC, Crippa A, Osondu CU, Valero-Elizondo J, Younus A, Nasir K, Veledar E. Estimates of mortality benefit from ideal cardiovascular health metrics: a dose response meta-analysis. J Am Heart Assoc. 2017;6(12):e006904.PubMedPubMedCentralCrossRef Aneni EC, Crippa A, Osondu CU, Valero-Elizondo J, Younus A, Nasir K, Veledar E. Estimates of mortality benefit from ideal cardiovascular health metrics: a dose response meta-analysis. J Am Heart Assoc. 2017;6(12):e006904.PubMedPubMedCentralCrossRef
28.
Zurück zum Zitat Fang N, Jiang M, Fan Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: a meta-analysis. Int J Cardiol. 2016;214:279–83.PubMedCrossRef Fang N, Jiang M, Fan Y. Ideal cardiovascular health metrics and risk of cardiovascular disease or mortality: a meta-analysis. Int J Cardiol. 2016;214:279–83.PubMedCrossRef
29.
Zurück zum Zitat Corlin L, Short MI, Vasan RS, Xanthakis V. Association of the duration of ideal cardiovascular health through adulthood with cardiometabolic outcomes and mortality in the framingham offspring study. JAMA Cardiol. 2020;5(5):549–56.PubMedCrossRef Corlin L, Short MI, Vasan RS, Xanthakis V. Association of the duration of ideal cardiovascular health through adulthood with cardiometabolic outcomes and mortality in the framingham offspring study. JAMA Cardiol. 2020;5(5):549–56.PubMedCrossRef
30.
Zurück zum Zitat Gao B, Wang F, Zhu M, Wang J, Zhou M, Zhang L, Zhao M. Cardiovascular health metrics and all-cause mortality and mortality from major non-communicable chronic diseases among Chinese adult population. Int J Cardiol. 2020;313:123–8.PubMedCrossRef Gao B, Wang F, Zhu M, Wang J, Zhou M, Zhang L, Zhao M. Cardiovascular health metrics and all-cause mortality and mortality from major non-communicable chronic diseases among Chinese adult population. Int J Cardiol. 2020;313:123–8.PubMedCrossRef
31.
Zurück zum Zitat Dong Y, Hao G, Wang Z, Wang X, Chen Z, Zhang L. Ideal Cardiovascular health status and risk of cardiovascular disease or all-cause mortality in chinese middle-aged population. Angiology. 2019;70(6):523–9.PubMedCrossRef Dong Y, Hao G, Wang Z, Wang X, Chen Z, Zhang L. Ideal Cardiovascular health status and risk of cardiovascular disease or all-cause mortality in chinese middle-aged population. Angiology. 2019;70(6):523–9.PubMedCrossRef
32.
Zurück zum Zitat Zhou L, Zhao L, Wu Y, Wu Y, Gao X, Li Y, Mai J, Nie Z, Ou Y, Guo M, et al. Ideal cardiovascular health metrics and its association with 20-year cardiovascular morbidity and mortality in a Chinese population. J Epidemiol Community Health. 2018;72(8):752–8.PubMedCrossRef Zhou L, Zhao L, Wu Y, Wu Y, Gao X, Li Y, Mai J, Nie Z, Ou Y, Guo M, et al. Ideal cardiovascular health metrics and its association with 20-year cardiovascular morbidity and mortality in a Chinese population. J Epidemiol Community Health. 2018;72(8):752–8.PubMedCrossRef
33.
Zurück zum Zitat Guo L, Zhang S. Association between ideal cardiovascular health metrics and risk of cardiovascular events or mortality: a meta-analysis of prospective studies. Clin Cardiol. 2017;40(12):1339–46.PubMedPubMedCentralCrossRef Guo L, Zhang S. Association between ideal cardiovascular health metrics and risk of cardiovascular events or mortality: a meta-analysis of prospective studies. Clin Cardiol. 2017;40(12):1339–46.PubMedPubMedCentralCrossRef
34.
Zurück zum Zitat Yang PS, Jang E, Yu HT, Kim TH, Pak HN, Lee MH, Joung B. Changes in cardiovascular risk factors and cardiovascular events in the elderly population. J Am Heart Assoc. 2021;10(11):e019482.PubMedPubMedCentralCrossRef Yang PS, Jang E, Yu HT, Kim TH, Pak HN, Lee MH, Joung B. Changes in cardiovascular risk factors and cardiovascular events in the elderly population. J Am Heart Assoc. 2021;10(11):e019482.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Han X, Jiang Z, Li Y, Wang Y, Liang Y, Dong Y, Tang S, Du Y, Qiu C. Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study. BMC Geriatr. 2021;21(1):158.PubMedPubMedCentralCrossRef Han X, Jiang Z, Li Y, Wang Y, Liang Y, Dong Y, Tang S, Du Y, Qiu C. Sex disparities in cardiovascular health metrics among rural-dwelling older adults in China: a population-based study. BMC Geriatr. 2021;21(1):158.PubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Gaye B, Canonico M, Perier MC, Samieri C, Berr C, Dartigues JF, Tzourio C, Elbaz A, Empana JP. Ideal cardiovascular health, mortality, and vascular events in elderly subjects: the three-city study. J Am Coll Cardiol. 2017;69(25):3015–26.PubMedCrossRef Gaye B, Canonico M, Perier MC, Samieri C, Berr C, Dartigues JF, Tzourio C, Elbaz A, Empana JP. Ideal cardiovascular health, mortality, and vascular events in elderly subjects: the three-city study. J Am Coll Cardiol. 2017;69(25):3015–26.PubMedCrossRef
37.
Zurück zum Zitat Ahmed A, Pinto Pereira SM, Lennon L, Papacosta O, Whincup P, Wannamethee G. Cardiovascular health and stroke in older British men: prospective findings from the British regional heart study. Stroke. 2020;51(11):3286–94.PubMedCrossRef Ahmed A, Pinto Pereira SM, Lennon L, Papacosta O, Whincup P, Wannamethee G. Cardiovascular health and stroke in older British men: prospective findings from the British regional heart study. Stroke. 2020;51(11):3286–94.PubMedCrossRef
38.
Zurück zum Zitat Deng Y, Gao Q, Yang D, Hua H, Wang N, Ou F, Liu R, Wu B, Liu Y. Association between biomass fuel use and risk of hypertension among Chinese older people: a cohort study. Environ Int. 2020;138:105620.PubMedCrossRef Deng Y, Gao Q, Yang D, Hua H, Wang N, Ou F, Liu R, Wu B, Liu Y. Association between biomass fuel use and risk of hypertension among Chinese older people: a cohort study. Environ Int. 2020;138:105620.PubMedCrossRef
39.
Zurück zum Zitat Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, Zhang J, Tian M, Huang L, Li Z, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021;385(12):1067–77.PubMedCrossRef Neal B, Wu Y, Feng X, Zhang R, Zhang Y, Shi J, Zhang J, Tian M, Huang L, Li Z, et al. Effect of salt substitution on cardiovascular events and death. N Engl J Med. 2021;385(12):1067–77.PubMedCrossRef
40.
Zurück zum Zitat Han C, Liu F, Yang X, Chen J, Li J, Cao J, Li Y, Shen C, Yu L, Liu Z, et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project. Sci China Life Sci. 2018;61(5):504–14.PubMedCrossRef Han C, Liu F, Yang X, Chen J, Li J, Cao J, Li Y, Shen C, Yu L, Liu Z, et al. Ideal cardiovascular health and incidence of atherosclerotic cardiovascular disease among Chinese adults: the China-PAR project. Sci China Life Sci. 2018;61(5):504–14.PubMedCrossRef
41.
Zurück zum Zitat Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58.PubMedCrossRef Lu J, Lu Y, Wang X, Li X, Linderman GC, Wu C, Cheng X, Mu L, Zhang H, Liu J, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1·7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–58.PubMedCrossRef
42.
Zurück zum Zitat Bi Y, Jiang Y, He J, Xu Y, Wang L, Xu M, Zhang M, Li Y, Wang T, Dai M, et al. Status of cardiovascular health in Chinese adults. J Am Coll Cardiol. 2015;65(10):1013–25.PubMedCrossRef Bi Y, Jiang Y, He J, Xu Y, Wang L, Xu M, Zhang M, Li Y, Wang T, Dai M, et al. Status of cardiovascular health in Chinese adults. J Am Coll Cardiol. 2015;65(10):1013–25.PubMedCrossRef
43.
Zurück zum Zitat Sanghavi M, Gulati M. Sex differences in the pathophysiology, treatment, and outcomes in IHD. Curr Atheroscler Rep. 2015;17(6):511.PubMedCrossRef Sanghavi M, Gulati M. Sex differences in the pathophysiology, treatment, and outcomes in IHD. Curr Atheroscler Rep. 2015;17(6):511.PubMedCrossRef
44.
Zurück zum Zitat Liu M, Kou F, Yang S, Wang S, He Y, Zhang W. Ideal cardiovascular health in the oldest-old and centenarians and its association with disability and health-related quality of life. Front Cardiovasc Med. 2021;8:603877.PubMedPubMedCentralCrossRef Liu M, Kou F, Yang S, Wang S, He Y, Zhang W. Ideal cardiovascular health in the oldest-old and centenarians and its association with disability and health-related quality of life. Front Cardiovasc Med. 2021;8:603877.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Yu Y, Dong Z, Li Y, Zhang J, Yin S, Gao X, Wu S. The cardiovascular and cerebrovascular health in North China from 2006 to 2011: results from the KaiLuan study. Front Cardiovasc Med. 2021;8:683416.PubMedPubMedCentralCrossRef Yu Y, Dong Z, Li Y, Zhang J, Yin S, Gao X, Wu S. The cardiovascular and cerebrovascular health in North China from 2006 to 2011: results from the KaiLuan study. Front Cardiovasc Med. 2021;8:683416.PubMedPubMedCentralCrossRef
46.
Zurück zum Zitat MI N, Kunutsor SK, Voutilainen A, Kurl S, Kauhanen J, AL J. Association between ideal cardiovascular health and risk of sudden cardiac death and all-cause mortality among middle-aged men in Finland. Eur J Prev Cardiol. 2021;28(3):294–300.CrossRef MI N, Kunutsor SK, Voutilainen A, Kurl S, Kauhanen J, AL J. Association between ideal cardiovascular health and risk of sudden cardiac death and all-cause mortality among middle-aged men in Finland. Eur J Prev Cardiol. 2021;28(3):294–300.CrossRef
47.
Zurück zum Zitat Isiozor NM, Kunutsor SK, Voutilainen A, Kurl S, Kauhanen J, Laukkanen JA. American heart association’s cardiovascular health metrics and risk of cardiovascular disease mortality among a middle-aged male Scandinavian population. Ann Med. 2019;51(5–6):306–13.PubMedPubMedCentralCrossRef Isiozor NM, Kunutsor SK, Voutilainen A, Kurl S, Kauhanen J, Laukkanen JA. American heart association’s cardiovascular health metrics and risk of cardiovascular disease mortality among a middle-aged male Scandinavian population. Ann Med. 2019;51(5–6):306–13.PubMedPubMedCentralCrossRef
48.
Zurück zum Zitat Han L, You D, Ma W, Astell-Burt T, Feng X, Duan S, Qi L. National trends in American heart association revised life’s simple 7 metrics associated with risk of mortality among US adults. JAMA Netw Open. 2019;2(10):e1913131.PubMedPubMedCentralCrossRef Han L, You D, Ma W, Astell-Burt T, Feng X, Duan S, Qi L. National trends in American heart association revised life’s simple 7 metrics associated with risk of mortality among US adults. JAMA Netw Open. 2019;2(10):e1913131.PubMedPubMedCentralCrossRef
49.
Zurück zum Zitat van Oort S, Beulens JWJ, van Ballegooijen AJ, Burgess S, Larsson SC. Cardiovascular risk factors and lifestyle behaviours in relation to longevity: a Mendelian randomization study. J Intern Med. 2021;289(2):232–43.PubMedCrossRef van Oort S, Beulens JWJ, van Ballegooijen AJ, Burgess S, Larsson SC. Cardiovascular risk factors and lifestyle behaviours in relation to longevity: a Mendelian randomization study. J Intern Med. 2021;289(2):232–43.PubMedCrossRef
Metadaten
Titel
Association of cardiovascular health at old age with all-cause mortality: a prospective cohort study in China
verfasst von
Shimin Chen
Haowei Li
Shengshu Wang
Shanshan Yang
Shaohua Liu
Yang Song
Xuehang Li
Rongrong Li
Jianhua Wang
Miao Liu
Yao He
Publikationsdatum
01.12.2023
Verlag
BioMed Central
Erschienen in
BMC Geriatrics / Ausgabe 1/2023
Elektronische ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-023-04093-9

Weitere Artikel der Ausgabe 1/2023

BMC Geriatrics 1/2023 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

CKD bei Diabetes: Neuheiten und Zukunftsaussichten

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Jeder Mensch mit Diabetes muss auf eine chronische Nierenerkrankung gescreent werden – diese neue Empfehlung spricht die KDIGO aus. Die Therapie erfolgt individuell und je nach Szenario mit verschiedenen Substanzklassen. Künftig kommt wahrscheinlich, neben RAS-Hemmung, SGLT2-Inhibition und nsMRA, eine vierte Therapiesäule hinzu.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.